M RE 150 (Risedronate Sodium 150 mg)
Pill with imprint M RE 150 is Blue, Round and has been identified as Risedronate Sodium 150 mg. It is supplied by Mylan Pharmaceuticals Inc.
Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M RE 150
Risedronate Sodium
- Imprint
- M RE 150
- Strength
- 150 mg
- Color
- Blue
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-4150 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
mannitol,
microcrystalline cellulose,
polydextrose,
titanium dioxide,
FD&C Blue No. 2,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Related images for "M RE 150"
More about risedronate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (65)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: bisphosphonates
Patient resources
- Drug Information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.